Analystreport

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was given a new $82.00 price target on by analysts at Roth Capital. They now have a "buy" rating on the stock.

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com